Filing Details
- Accession Number:
- 0001209191-24-004847
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-14 21:22:43
- Reporting Period:
- 2024-03-12
- Accepted Time:
- 2024-03-14 21:22:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1020214 | Cerus Corp | CERS | Surgical & Medical Instruments & Apparatus (3841) | 680262011 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1193209 | M Laurence Corash | C/O Cerus Corporation 1220 Concord Ave Suite 600 Concord CA 94520 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-12 | 16,666 | $0.00 | 2,368,167 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-13 | 14,067 | $2.06 | 2,354,100 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-14 | 14,360 | $1.97 | 2,339,740 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2024-03-12 | 16,666 | $0.00 | 16,666 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.
- Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person.
- The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
- The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
- The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.
- Not applicable.
Billionaire Hedge Funds
